masoprocol and Brain Neoplasms

masoprocol has been researched along with Brain Neoplasms in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (33.33)18.2507
2000's4 (33.33)29.6817
2010's4 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bian, X; Chen, G; Cui, W; Cui, Y; Gu, A; Li, T; Xu, C; Yang, X; Yu, S; Zhang, X1
Bian, XW; Cui, W; Cui, YH; Dang, WQ; Kung, HF; Ma, LN; Ping, YF; Qian, C; Shi, Y; Wang, B; Wang, QL; Wang, Z; Xiao, HL; Xu, C; Xu, SL; Yang, L; Yu, SC; Zhang, X1
Desideri, S; Grossman, SA; Mikkelsen, T; Peereboom, D; Rosenfeld, MR; Supko, JG; Ye, X1
Borges, KS; Carlotti, CG; Castro-Gamero, AM; de Oliveira, HF; de Paula Gomes Queiroz, R; Fujinami, MM; Moreno, DA; Scrideli, CA; Suazo, VK; Tone, LG1
Bai, JS; Bian, XW; Chen, JH; Dai, C; Jiang, XF; Liu, MY; Lu, JY; Shi, JQ; Wang, JM; Wang, QL; Xin, R; Zhao, W1
Bian, XW; Chen, DL; Chen, JH; Liu, H; Ping, YF; Wang, JM; Yao, XH; Zhou, XD1
Bian, XW; Chen, JH; Liu, H; Wu, YZ; Xu, JP; Zhou, XD1
Kanfer, JN; Singh, IN; Sitar, DS; Sorrentino, G1
Bian, X; Shi, J; Xin, R1
Guan, Z; Saqr, HE; Stokes, BT; Yates, AJ1
Bian, X; Chen, Y; Shi, J; Sun, H1
Baba, T; Black, KL; Chio, CC1

Trials

1 trial(s) available for masoprocol and Brain Neoplasms

ArticleYear
Phase I study of terameprocol in patients with recurrent high-grade glioma.
    Neuro-oncology, 2012, Volume: 14, Issue:4

    Topics: Adult; Aged; Anticonvulsants; Antineoplastic Agents; Brain Neoplasms; Disease Progression; Dose-Response Relationship, Drug; Female; Glioma; Humans; Male; Masoprocol; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Treatment Outcome

2012

Other Studies

11 other study(ies) available for masoprocol and Brain Neoplasms

ArticleYear
A synthetic dl-nordihydroguaiaretic acid (Nordy), inhibits angiogenesis, invasion and proliferation of glioma stem cells within a zebrafish xenotransplantation model.
    PloS one, 2014, Volume: 9, Issue:1

    Topics: AC133 Antigen; Animals; Antigens, CD; Antineoplastic Agents; Brain Neoplasms; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Glioma; Glycoproteins; Humans; Masoprocol; Neoplasm Invasiveness; Neoplastic Stem Cells; Neovascularization, Pathologic; Peptides; Receptors, Vascular Endothelial Growth Factor; Xenograft Model Antitumor Assays; Zebrafish

2014
Oncogenic miR-20a and miR-106a enhance the invasiveness of human glioma stem cells by directly targeting TIMP-2.
    Oncogene, 2015, Mar-12, Volume: 34, Issue:11

    Topics: AC133 Antigen; Animals; Antigens, CD; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Down-Regulation; Gene Expression Regulation, Neoplastic; Glioblastoma; Glycoproteins; Humans; Lipoxygenase Inhibitors; Male; Masoprocol; Mice; Mice, Nude; MicroRNAs; Neoplasm Invasiveness; Neoplasm Transplantation; Neoplastic Stem Cells; Peptides; RNA Interference; RNA, Small Interfering; Tissue Inhibitor of Metalloproteinase-2; Transplantation, Heterologous

2015
Tetra-O-methyl nordihydroguaiaretic acid, an inhibitor of Sp1-mediated survivin transcription, induces apoptosis and acts synergistically with chemo-radiotherapy in glioblastoma cells.
    Investigational new drugs, 2013, Volume: 31, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Brain Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Dacarbazine; Dose-Response Relationship, Drug; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Inhibitor of Apoptosis Proteins; Inhibitory Concentration 50; Male; Masoprocol; Mitotic Index; Radiation-Sensitizing Agents; RNA Splicing; RNA, Messenger; Sp1 Transcription Factor; Survivin; Temozolomide; Transcription, Genetic

2013
Increased angiogenic capabilities of endothelial cells from microvessels of malignant human gliomas.
    International immunopharmacology, 2006, Volume: 6, Issue:1

    Topics: Astrocytoma; Brain Neoplasms; Cell Line; Cells, Cultured; Endothelium, Vascular; Glioblastoma; Glioma; Humans; Immunomagnetic Separation; In Vitro Techniques; Lignans; Masoprocol; Microcirculation; Models, Biological; Neovascularization, Pathologic; Spheroids, Cellular; Vascular Endothelial Growth Factor A

2006
The anti-cancer compound Nordy inhibits CXCR4-mediated production of IL-8 and VEGF by malignant human glioma cells.
    Journal of neuro-oncology, 2007, Volume: 84, Issue:1

    Topics: Analysis of Variance; Angiogenic Proteins; Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Down-Regulation; Gene Expression Regulation, Neoplastic; Glioma; Humans; Interleukin-8; Lignans; Lipoxygenase Inhibitors; Masoprocol; Mice; Mice, Inbred BALB C; Mice, Nude; Receptors, CXCR4; RNA, Messenger; Vascular Endothelial Growth Factor A

2007
[Effect of nordy on biological behaviors of malignant glioma cell line U87MG and the analysis of differential expression proteome].
    Zhonghua bing li xue za zhi = Chinese journal of pathology, 2007, Volume: 36, Issue:9

    Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Glial Fibrillary Acidic Protein; Glioblastoma; Humans; Lipoxygenase Inhibitors; Male; Masoprocol; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Protein Array Analysis; Proteome; Proteomics; Random Allocation; Tumor Burden

2007
Indomethacin and nordihydroguaiaretic acid inhibition of amyloid beta protein (25-35) activation of phospholipases A2 and D of LA-N-2 cells.
    Neuroscience letters, 1997, Jan-24, Volume: 222, Issue:1

    Topics: Amyloid beta-Protein Precursor; Brain Neoplasms; Dose-Response Relationship, Drug; Humans; Indomethacin; Masoprocol; Neuroblastoma; Phospholipases; Tumor Cells, Cultured

1997
[Effects of nordihydroguaiaretic acid on the growth and differentiation of SHG-44 glioma cell line].
    Zhonghua bing li xue za zhi = Chinese journal of pathology, 1997, Volume: 26, Issue:5

    Topics: Brain Neoplasms; Cell Division; Cell Transformation, Neoplastic; Glioblastoma; Humans; Lipoxygenase Inhibitors; Masoprocol; Microinjections; Tumor Cells, Cultured

1997
Mechanisms through which PDGF alters intracellular calcium levels in U-1242 MG human glioma cells.
    Neurochemistry international, 1999, Volume: 35, Issue:6

    Topics: Becaplermin; Brain Neoplasms; Caffeine; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium Signaling; Calcium-Transporting ATPases; Elapid Venoms; Endoplasmic Reticulum; Enzyme Inhibitors; Flufenamic Acid; Glioma; Humans; Imidazoles; Ion Transport; Masoprocol; Neoplasm Proteins; Nicardipine; Nimodipine; Nitrendipine; omega-Agatoxin IVA; omega-Conotoxin GVIA; omega-Conotoxins; Peptides; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-sis; Ryanodine; Thapsigargin; Tumor Cells, Cultured; Verapamil

1999
[The effect of nordihydroguaiaretic acid on endothelial cell migration induced by glioma cells].
    Zhonghua bing li xue za zhi = Chinese journal of pathology, 2000, Volume: 29, Issue:1

    Topics: Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cells, Cultured; Coculture Techniques; Endothelial Cells; Fibroblast Growth Factor 2; Glioblastoma; Humans; Masoprocol; Umbilical Veins; Vascular Endothelial Growth Factor A

2000
The effect of 5-lipoxygenase inhibition on blood-brain barrier permeability in experimental brain tumors.
    Journal of neurosurgery, 1992, Volume: 77, Issue:3

    Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Analysis of Variance; Animals; Autoradiography; Benzoquinones; Blood-Brain Barrier; Brain Neoplasms; Carcinoma 256, Walker; Female; gamma-Glutamyltransferase; Leukotrienes; Lipoxygenase Inhibitors; Masoprocol; Rats; Rats, Inbred Strains

1992